Healthcare organizations in the U.S. use AI systems more often to handle patient data, help with clinical decisions, and manage tasks like scheduling and appointments. AI tools can quickly process large amounts of personal medical information, which can make healthcare work better. But this means sensitive patient data is used in AI systems. It is important to protect this data and make sure AI does not harm patients or break their rights.
Sometimes, AI systems work on their own, using algorithms to make choices or suggest treatments for patients. Without good rules, these systems might make mistakes, be unfair, or treat some patients wrong. So, strong rules and data protection are very important. National authorities must make sure AI in healthcare meets high safety and privacy rules because medical information is very private.
The United States does not have one big federal law like Europe’s General Data Protection Regulation (GDPR) or the new EU AI Act. But the U.S. can learn from these laws. The EU GDPR, started in 2018, protects personal data and gives people strong control over their data. The EU AI Act, made official in early 2024, makes sure AI is safe and used the right way, especially in areas like healthcare.
In Europe, data protection authorities (DPAs) carefully make sure these laws are followed to protect patients. For example, the Italian DPA temporarily stopped OpenAI’s ChatGPT due to privacy worries. The French DPA fined Clearview AI for using millions of images illegally. These actions show how serious patient data and AI safety are in Europe.
Even though the U.S. has a different healthcare system, these global efforts show how much oversight is needed. U.S. national and state authorities, like the Department of Health and Human Services’ Office for Civil Rights (OCR), enforce HIPAA. HIPAA requires privacy and security for patient health information. As AI grows, there is more interest in making sure AI tools in healthcare follow rules about fairness, openness, and human control.
In the U.S., many authorities help regulate AI use in healthcare. These include government agencies, professional groups, and organizations that set standards. Their jobs sometimes overlap, so they must work together clearly.
Together, these authorities work to make sure AI in healthcare is safe and respects privacy. But unlike Europe’s clear GDPR and AI Act, the U.S. has many rules and agencies. This can make it harder for healthcare managers to handle AI use.
National authorities focus on basic principles that healthcare AI must follow:
In Europe, these ideas are part of laws like GDPR and the EU AI Act. These laws ask organizations to do risk checks called Data Protection Impact Assessments (DPIAs) or Fundamental Rights Impact Assessments (FRIAs) to find risks with AI. The U.S. does not require these exact steps, but similar risk checks and detailed records are good practice for healthcare AI projects.
One big way AI is changing healthcare is by automating front-office and admin tasks. Companies like Simbo AI create AI systems to answer phones and run front desk jobs. This can cut down patient wait times, improve patient contact, and help when call volumes are high or outside office hours.
This automation uses AI that understands natural language to answer patient questions, schedule visits, or give basic info without a person. This lets staff focus on more important work and makes the office run smoother.
But these AI systems must follow privacy laws and get patient permission. Since they handle personal info like names, birthdates, and health questions, protecting this data is very important. The AI should be built with privacy as a core idea, avoiding extra data collection or insecure storage.
Also, national authorities would see these front-office AI tools as less risky than AI that helps with medical decisions. Still, it is important to be open about when AI is being used. Patients should know they are talking to an AI and how their data is handled.
Healthcare managers need to remember that using AI for workflows does not remove their duty to follow rules. They must do audits, run security tests often, and train staff well.
Even with progress in AI and rules, U.S. healthcare groups face several challenges:
National authorities in the United States play a key role in enforcing laws that make sure AI in healthcare respects patient rights and privacy. By learning from international examples like the EU GDPR and EU AI Act, U.S. healthcare providers can improve their rules and use AI responsibly. AI-driven workflow automations, such as those by Simbo AI, show how AI can reduce office work while keeping data safe.
In the end, medical practice leaders, owners, and IT staff must keep up with new rules. They need to put in place protections that balance new technology with patient safety and rights.
The EU AI Act is primarily a product safety law ensuring the safe development and use of AI systems, while the GDPR is a fundamental rights law providing individual data protection rights. They are designed to work together, with the GDPR filling gaps related to personal data protection when AI systems process data about living individuals.
The GDPR is technology-neutral and applies broadly to any processing of personal data, including by AI systems in healthcare. Since AI systems often handle personal data throughout development and operation, GDPR principles like data minimisation, lawfulness, and transparency must be observed.
DPAs have acted on issues such as lacking legal basis for data processing, transparency failures, abuse of automated decisions, and inaccurate data processing. Examples include fines to Clearview AI and bans on ChatGPT in Italy, underscoring DPAs’ active role in policing AI under GDPR.
Controllers under the GDPR determine data processing purposes, while providers develop AI systems and deployers use them under the EU AI Act. Organizations often have dual roles, processing personal data as controllers while also acting as providers or deployers of AI systems.
Key GDPR principles include lawfulness, fairness, transparency, purpose limitation, data minimisation, accuracy, storage limitation, integrity, and confidentiality. These principles require healthcare AI to process personal data responsibly, ensuring patient rights and privacy are respected throughout AI use.
The EU AI Act mandates ‘human-oversight-by-design’ for high-risk AI systems to allow natural persons to effectively intervene, complementing GDPR Article 22, which restricts solely automated decisions without meaningful human intervention impacting individuals’ rights.
The GDPR requires Data Protection Impact Assessments (DPIAs) for high-risk personal data processing, while the EU AI Act mandates conformity assessments and Fundamental Rights Impact Assessments (FRIAs) for high-risk AI systems to ensure compliance and rights protection.
The GDPR has extraterritorial reach, applying to controllers and processors established in the EU or targeting EU individuals, regardless of data location. The EU AI Act applies to providers, deployers, and other operators within the EU, ensuring AI safety across member states.
Both regulations stress transparency, requiring clear communication on AI use, data processing purposes, and decision-making logic. The EU AI Act adds specific transparency duties for certain AI categories, ensuring patients and healthcare providers understand AI interactions affecting personal data.
National competent authorities will supervise EU AI Act enforcement, performing market surveillance, and DPAs will enforce data protection laws including GDPR compliance with AI systems. Their collaborative role strengthens oversight of AI in healthcare, protecting fundamental rights and data privacy.